A ONE YEAR EXPERIENCE: T CELL RESPONSES AND VIRAL REPLICATION IN CHILDREN WITH ADVANCED HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 DISEASE TREATED WITH COMBINATION THERAPY INCLUDING RITONAVIR

This publication has 6 references indexed in Scilit:

• CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)
  The Lancet, 1998
• Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease
  The Lancet, 1998
• Clinical, virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors
  The Pediatric Infectious Disease Journal, 1997
• A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
  New England Journal of Medicine, 1997
• Changes in Plasma HIV RNA Levels and CD4+ Lymphocyte Counts Predict Both Response to Antiretroviral Therapy and Therapeutic Failure
  Annals of Internal Medicine, 1997
• The Relationship between Serum Human Immunodeficiency Virus Type 1 (HIV‐1) RNA Level, CD4 Lymphocyte Percent, and Long‐Term Mortality Risk in HIV‐1—Infected Children
  The Journal of Infectious Diseases, 1997